SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 670-680, abril 2022. ilus, tab
Artigo
em Inglês
| IBECS
| ID: ibc-203771
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Terapêutica
/
Neoplasias Nasofaríngeas
/
Diagnóstico
/
Carcinoma Nasofaríngeo
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Catalan Institut of Oncology/Spain
/
Complejo Hospitalario Universitario de Ourense/Spain
/
Complejo Hospitalario de Navarra/Spain
/
Hospital Josep Trueta/Spain
/
Hospital Marqués de Valdecilla/Spain
/
Hospital Universitario Lucus Augusti/Spain
/
Hospital Universitario de La Paz/Spain
/
Hospital Virgen de La Salud/Spain
/
Regional and Virgen de La Victoria University Hospitals/Spain
